降气化痰法治疗急性发作期支气管哮喘34例临床的研究.docVIP

降气化痰法治疗急性发作期支气管哮喘34例临床的研究 　　摘 要 目的：分析降气化痰法辅助治疗支气管哮喘急性发作期的临床疗效。方法：选择支气管哮喘急性发作期患者34例为观察组，选择同期支气管哮喘急性发作期患者32例为对照组，两组患者均予吸氧、祛痰、止咳等常规治疗，观察组在此基础上辅助应用降气化痰法为基础清肺平喘方的中药汤剂。比较两组临床疗效，治疗前后症候积分、主症积分和、FEV1、FVC及PEFR等肺功能变化情况。结果：观察组总有效率高于对照组，差异有统计学意义（P0.05）；治疗后，两组证候积分及主症积分和均较治疗前下降，FEV1、FVC及PEFR均较治疗前增加，两组组内及组间差异均有统计学意义（P0.05）。结论：在西药基础上应用降气化痰法治疗支气管哮喘急性发作期可缓解患者临床症状，提高临床疗效，改善患者的肺功能。 　　关键词 降气化痰法 支气管哮喘急性发作期 肺功能 　　中图分类号：R562.25； R289.5 文献标识码：B 文章编号：1006-1533（2018）01-0027-02 　　Clinical research of Jiangqi Huatan decoction in the treatment of 34 cases of acute exacerbation of bronchial asthma 　　HAN Shengbin 　　（Department of Pulmonary Disease， Kaifeng Hospital of TMC， Kaifeng 475000， China） 　　ABSTRACT Objective： To explore the effects of adjuvant therapy of Jiangqi Huatan decoction on acute exacerbation of bronchial asthma. Methods： Sixty-six cases of patients with acute exacerbation of bronchial asthma were selected and divided into an observation group （34 cases） and a control group （32 cases）. All the patients underwent routine treatment such as oxygen inhalation， expectorant and a cough relieving and Chinese medicine decoction was taken in the observation group besides. The clinical effects and the changes of TCM symptoms score， cardinal symptom， FEV1， FVC and PEFR were compared between the two groups. Results： The clinical effects were much better in the observation group than in the control group （P0.05）， however， TCM symptoms scores and cardinal symptoms were decreased and the FEV1， FVC and PEFR were increased in all the patients after treatment （P0.05）. Conclusion： Jiangqi Huatan decoction plus western medicine can relieve the symptoms and improve the efficacy and pulmonary function of the patients. 　　KEY WORDS Jiangqi Huatan decoction； acute exacerbation of bronchial asthma； pulmonary function 　　支?夤芟?喘是呼吸系统常见病和多发病，是一种以慢性气道炎症为特征，多种细胞组分和细胞共同参与的异质性疾病[1]。据保守估计，我国目前约有1 500～2 000万支气管哮喘患者，且近年来其发病率呈不断增长的趋势[2]。支气管哮喘急性发作期临床症状表现为呼吸困难、咳嗽、咯痰、胸痛等，严重时可导致患者死亡，是哮喘患者的主要健康负担。研究表明[3]，中医药可减少哮喘急性